Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Bioprospecting the American Alligator (Alligator mississippiensis) Host Defense Peptidome.

Bishop BM, Juba ML, Devine MC, Barksdale SM, Rodriguez CA, Chung MC, Russo PS, Vliet KA, Schnur JM, van Hoek ML.

PLoS One. 2015 Feb 11;10(2):e0117394. doi: 10.1371/journal.pone.0117394. eCollection 2015.

PMID:
25671663
[PubMed - in process]
Free PMC Article
2.

Helical cationic antimicrobial peptide length and its impact on membrane disruption.

Juba ML, Porter DK, Williams EH, Rodriguez CA, Barksdale SM, Bishop BM.

Biochim Biophys Acta. 2015 Feb 3;1848(5):1081-1091. doi: 10.1016/j.bbamem.2015.01.007. [Epub ahead of print]

PMID:
25660753
[PubMed - as supplied by publisher]
3.

Potential and emerging treatment options for Ebola virus disease.

Bishop BM.

Ann Pharmacother. 2015 Feb;49(2):196-206. doi: 10.1177/1060028014561227. Epub 2014 Nov 20.

PMID:
25414384
[PubMed - in process]
4.

Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Bishop BM.

Am J Health Syst Pharm. 2014 Nov 1;71(21):1839-44. doi: 10.2146/ajhp130777. Review.

PMID:
25320133
[PubMed - in process]
5.

Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit.

Bishop BM, Bon JJ, Trienski TL, Pasquale TR, Martin BR, File TM Jr.

Ann Pharmacother. 2014 May;48(5):577-83. doi: 10.1177/1060028014520957. Epub 2014 Feb 11.

PMID:
24519479
[PubMed - indexed for MEDLINE]
6.

Systematic Review of CETP Inhibitors for Increasing High-Density Lipoprotein Cholesterol: Where Do These Agents Stand in the Approval Process?

Bishop BM.

Am J Ther. 2015 Mar-Apr;22(2):147-58. doi: 10.1097/MJT.0b013e31828b8463.

PMID:
23567794
[PubMed - in process]
7.

Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.

Bishop BM, Mauro VF, Khouri SJ.

Pharmacotherapy. 2012 Sep;32(9):838-55. doi: 10.1002/j.1875-9114.2012.01114.x. Epub 2012 Jul 17. Review.

PMID:
22806762
[PubMed - indexed for MEDLINE]
8.

Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37.

Dean SN, Bishop BM, van Hoek ML.

Front Microbiol. 2011 Jul 4;2:128. doi: 10.3389/fmicb.2011.00128. eCollection 2011.

PMID:
21772832
[PubMed]
Free PMC Article
9.

Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus.

Dean SN, Bishop BM, van Hoek ML.

BMC Microbiol. 2011 May 23;11:114. doi: 10.1186/1471-2180-11-114.

PMID:
21605457
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antimicrobial activity of the Naja atra cathelicidin and related small peptides.

de Latour FA, Amer LS, Papanstasiou EA, Bishop BM, van Hoek ML.

Biochem Biophys Res Commun. 2010 Jun 11;396(4):825-30. doi: 10.1016/j.bbrc.2010.04.158. Epub 2010 May 10.

PMID:
20438706
[PubMed - indexed for MEDLINE]
11.

Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella.

Amer LS, Bishop BM, van Hoek ML.

Biochem Biophys Res Commun. 2010 May 28;396(2):246-51. doi: 10.1016/j.bbrc.2010.04.073. Epub 2010 Apr 23.

PMID:
20399752
[PubMed - indexed for MEDLINE]
12.

Role of acetylation and charge in antimicrobial peptides based on human beta-defensin-3.

Papanastasiou EA, Hua Q, Sandouk A, Son UH, Christenson AJ, Van Hoek ML, Bishop BM.

APMIS. 2009 Jul;117(7):492-9. doi: 10.1111/j.1600-0463.2009.02460.x.

PMID:
19594489
[PubMed - indexed for MEDLINE]
13.

Antimicrobial activity of human beta-defensins and induction by Francisella.

Han S, Bishop BM, van Hoek ML.

Biochem Biophys Res Commun. 2008 Jul 11;371(4):670-4. doi: 10.1016/j.bbrc.2008.04.092. Epub 2008 Apr 29.

PMID:
18452706
[PubMed - indexed for MEDLINE]
14.

Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.

Hermonat PL, Santin AD, De Greve J, De Rijcke M, Bishop BM, Han L, Mane M, Kokorina N.

J Hum Virol. 1999 Nov-Dec;2(6):359-68.

PMID:
10774553
[PubMed - indexed for MEDLINE]
15.

The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors.

Hermonat PL, Quirk JG, Bishop BM, Han L.

FEBS Lett. 1997 Apr 21;407(1):78-84.

PMID:
9141485
[PubMed - indexed for MEDLINE]
Free Article
16.

Role of the terminal repeat GAGC trimer, the major Rep78 binding site, in adeno-associated virus DNA replication.

Bishop BM, Santin AD, Quirk JG, Hermonat PL.

FEBS Lett. 1996 Nov 11;397(1):97-100.

PMID:
8941722
[PubMed - indexed for MEDLINE]
Free Article
17.

A comparison of aesthetic inlay systems.

Bishop BM.

Ann R Australas Coll Dent Surg. 1994 Apr;12:119-30. Review.

PMID:
7993040
[PubMed - indexed for MEDLINE]
18.

A comparative study of the apical leakage of four root canal sealers and laterally condensed gutta-percha.

Limkangwalmongkol S, Burtscher P, Abbott PV, Sandler AB, Bishop BM.

J Endod. 1991 Oct;17(10):495-9.

PMID:
1812194
[PubMed - indexed for MEDLINE]
19.

A heat and pressure cured composite inlay system: a clinical evaluation.

Bishop BM.

Aust Prosthodont J. 1989;3:35-41.

PMID:
2638872
[PubMed - indexed for MEDLINE]
20.

An in vitro study of the effect of moisture on glass-ionomer cement.

Phillips S, Bishop BM.

Quintessence Int. 1985 Feb;16(2):175-7. No abstract available.

PMID:
3857663
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk